Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study

Introduction: Since the coronavirus disease 2019 (COVID-19) pandemic, the use of angiotensin II receptor blockers (ARBs) in hypertensive patients with COVID-19 has been controversial. Following our previous study, after one year, we intended to extend our sample size and results to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadadi, Azar, Kazemian, Sina, Shafie, Mahan, Ahmadi, Arezoo, Soleimani, Abbas, Ashraf, Haleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871165/
https://www.ncbi.nlm.nih.gov/pubmed/36699557
http://dx.doi.org/10.34172/jcvtr.2022.30559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871165/
https://www.ncbi.nlm.nih.gov/pubmed/36699557
http://dx.doi.org/10.34172/jcvtr.2022.30559

Ejemplares similares